Article Text
LETTER
Proton pump inhibitor-therapy refractory gastro-oesophageal reflux disease patients, who are they?
Statistics from Altmetric.com
In a recent version of Gut, Mainie and colleagues report on patients with persistent symptoms despite acid suppressive therapy.1 This is often presented as a considerable problem and impedance seems useful in the evaluation of these patients. The importance of the phenomenon of proton pump inhibitor(PPI)-refractory symptoms is also stressed in studies in which the need for a new anti-reflux drug is propagated. However, we think some caution is appropriate when speaking of PPI-refractory gastro-oesophageal reflux disease …
Footnotes
Competing interest: None.